Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's because he never spoke to Les but was just responding in a satirical way to someone else's comment.
This is a message board and anything and everything should be absorbed with a healthy pinch of salt unless that information can be linked to actual facts.
While we wait for the publication a suggestion is to just sit back and relax, once that event arrives we will have plenty to talk about I am sure.
IMO the only relevant objective going forward for NWBO now that their shareholders have voiced their support is to make sure they start delivering starting with the publication before they start going back for more financing.
It is time that they start taking their job of delivering seriously and that should start with increasing SP and market cap and avoid toxic financing at all costs.
I look forward to a concerted and timed effort by the company leading into ASCO to get the short nonsense squared away by delivering on blinded paper and spring refresh results as well as starting some additional trials with L and re-starting Direct trials.
With a string of news leading into ASCO I believe the market in general will start taking this companies future seriously and this will of course reflect on the SP and have a massive effect on any future financing required by LP and team.
We as shareholders will of course be reflecting on our own genius in backing this little Bio.
And what we always have to remember is that if the information they may have had access to was truly negative this type of information would have had to be disclosed to all investors.
The only type of information that he has had to go into silence mode for would be positive IMHO and this information is most likely linked to the the German improvements and results of these improvements.
You give far much credit to a single scientist regarding Dendritic Cell Vaccines. The reality here is that the rest of the world is playing catchup to the science that Linda Liau and her UCLA team have been working on and perfecting for all these years. NWBO has many many patents covering this tech for both L and D so your assertions that the rest of the world are overtaking countless years of research and perfection are pie in the sky.
Another thing, how many of these so called new technologies are in pre commercial studies such as L which if it passes will be approved not only for GBM but for all operable tumors.
It sounds like you may have some new Dendritic Cell vaccines to invest in along with the help/speculation of your scientist friend. Time to cash in here and move your money to the technologies you think are in the process of overtaking as well as finding brand new more viable ways of operating that do not cross NWBO's patents.
Good luck to you.
My bad BSB, having a bad day and misreading. You are of course right in your assessment. Enjoy the weekend, cracking open a cool one to null away the frustrations, which have nothing to do with NWBO of which I still have supreme confidence.
So what you are saying is that the OTC markets are never manipulated and Wall Street is completely honest. While money is the ruler of mankind expect dishonesty at every turn. Telling people that the markets are honest is akin to saying that Vegas does not love your money. Their is one thing that is true about Vegas and the markets, they only love to take your money .
Looks like PUMA wants to get in the game. What does this mean, well they are either looking to accumulate ahead of an anticipated public event or covering a short position ahead of a positive move to the upside. To me a positive but for traders looking to get in and out this usually means stagnation for a while.
Simple rule regarding shares vs value. When you have found a stock done the DD and believe 100% in the company you buy the stock at the best entry point available at the time. Once an entry has been made you continue to buy on the dips from that entry point and never concern yourself about the dollar value. Wall street and shorts continually play the emotional game with retail buyers hoping that they are hooked into the dollar value vs the number of shares owned. Everyday they play on the emotions of the dumb money as they like to refer to retail buyers and sadly a high percentage of the time they steal away those retails hard earned money, usually at a point way below their respective entry points.
To win on any stock purchase that you believe in play the game of these ruthless players and look for their attacks and buy more at manipulated levels and never look at the cash value.
The only time the cash value should ever mean anything is when the company you believe in starts to break out. At that point your strategy should be based on an exit plan and maximizing your profits.
If NWBO is serious about going it alone once endpoints are met with L then we should see many years of growth ahead of us. I also believe that the current price levels will soon be a distant memory and all that fretting of penny gains and losses through short manipulation will end up just being a lesson to many.
Are we on the brink of history and a move away from BP supported cancer treatments. Will NWBO and dendritic personalized vaccines pave a way toward a cure and prevention of the worst disease afflicted on mankind.
I believe so.
Absolutely, today a massive $230,000 were traded between these low life MM's trying to scare monger. Unfortunately no matter what they try to do as evidenced by the type of pi$$ poor volume used these last couple of weeks to shred the SP no one is selling. Most of the dumb money has long since left and no matter what they try it ain't working.
Trend will be reversed soon.
Your post clearly shows that you have an IQ of room temperature.
So you call 930,000 shares swapping hands massive selling. What planet are you from. This is .22% of the current shares. This downward pressure on such pi$$ poor volume is nothing but manipulation by the MM's. Come back to me when volume exceeds 50 million.
Been a fun day to watch this ride and to all those who sold in panic well just let's say biotech's are not for the emotional investors. As for a continued sell off, the only sellers will be emotional small time sellers or nefarious investors who have a ton of stocks purchased at cut throat deals that they can use to lower the price to generate more emotional selling. Strike while the iron is hot for any shorts still in this game. Cannot see any real investors selling at these levels only buying IMHO. I hear talk of pennies in a couple of weeks but lets not forget that any stocks coming in from the dilution were bought at a price by incoming investors so how does this relate to any current valuation. Valuation of a stock is determined by what people are prepared to buy stocks at. Bringing this stock to pennies will just confirm the existence of dark forces intent in busting this company. This next 6 weeks will be interesting and if you are a long and believe in the science well let's just say that there may be many buying opportunities until the first material event. Now if only we knew when this will occur.
This 10K is basically a regurgitation of last years 10K which in essence means that the company has spent multiple millions and not progressed at all.
They are now looking for 3X dilution for basically spinning the wheels of their current trials.
1) DCVAX-L Trial. Unblind date is unknown. We are all so blind now we are prepared to blindly vote "yes" to 3X dilution and massive board compensation with absolutely no idea when and if this trial will ever end. Meanwhile competitors are able to get statistical evidence after 10.5 months not 10.5 years. If this represents the Holy Grail of cancer cure then we the investors are the Monty Python crew looking for the Holy Grail while the rest of the world laughs at us.
2) DCVAX-D Trial. No progress at all. Even though this trial spread fear into BP's supposedly, NWBO in all it's infinite wisdom have decided it is so damn good it is not worth pursuing any more.
3) DCVAX-L Combo Trials. Continual cycle of delay after delay. No progress at all except another note from the company informing it's legion of salivating investors that they will have to wait another 6 months. The blind donkey is finding it very hard to sniff out this carrot anymore.
4) DCVAX-L Blinded Interim Paper by 67 scientists. Where is that "DAMN" paper, most likely being used as toilet paper in the yet to be completed manufacturing facility in Sawston owned by Advent which is owned by whom. Well who the hell knows except the person using the manuscript as toilet paper. Now that person has more knowledge than all us dumb blind investors hoping and praying for a golden carrot that at some point in the future be delivered by the esteemed and honorable CEO of NWBO.
Still waiting on news patiently and hoping that all of us longs on this board wont have to munch on those damn carrots for much longer because that s**t is getting old.
Any news from NWBO is paramount before the vote on 27th.
Just to release an 8K informing investors that they are committed to finally unblinding the DCVAX-L trial good or bad in 2018 will in itself constitute recognition from the market that news is imminent.
Without a shred of detail regarding future plans and asking investors to vote blindly for 3X dilution and at the same time compensate the board with millions of shares constitutes to gross negligence of all current shareholders.
Let's be very clear that the reason the SP sits at 22 cents is that the board of directors continue to remain completely and utterly silent.
Voting yes blindly, identifies a person as having blind faith and blind faith in anything is extremely dangerous and in this case dangerous to your very own investment.
The delayed publication based on last Springs data is now irrelevant as the company should be acting on this years refresh and planning on unblinding the trial. Boasting about 67 scientists in itself constituted a lack of foresight as just 10 highly respected and trusted scientists would have been just as relevant and most likely led to a much earlier release. Any number of the 67 scientists could have nefarious intentions such as delaying the publication if sign off was required in any amendments.
Why can NWBO at least inform the shareholders of when this publication will be delivered. This information in itself will be regarded as positive and lead to interest. Not giving any information about the publication constitutes that they have already written this off as relevant. That "damn" article statement by Linda Powers should have been taken as a massive red flag as that damn article sounds like it was damned from the moment it hit the publicists desk and at no fault of the publisher themselves.
We as shareholders should have as much right to be given information shared with incoming shareholders even if it means all of us signing NDA's. But this would constitute trust from NWBO and if they are unwilling to trust us with information why should we just blindly trust them and vote "YES" to making us poorer and giving them an open ATM to continue their cycle of toxic financing and consigning us to oblivion.
A typical MM strategy to pretend there is a massive buyer. Price is walked down to the ask and when it is reached the magical buyer melts away. This manipulation happens all the time and has been used very successfully these past few weeks to drive the price down on very low volume.
All new players to Dendritic Cell Vaccines are way behind the UCLA team and are just scrambling to get a foothold in what they know will become a platform technology very soon. NWBO/UCLA will soon wrap this up IMHO and continue to advance this technology over the coming years. The coming months should prove very interesting. A once derided science by the big BP's will become the shining star in the worlds fight against cancer.
So it looks like there will be no publication or any news between now and the vote. I do not like the idea that the journal is now going through further edits based on new information as this would mean nothing before ASCO itself. If this is what you have heard as the new line given by Les then what news will be delivered leading into ASCO that will in anyway attract new buyers to the cause.
The FUDsters on this board are trying to promote the theory that the stock will dive into the pennies but hey they must have failed high school arithmetic. The lowest this stock will go is the level that the new stock being delivered through the dilution were bought at so 17c may be reached with no news at all.
It looks like no news until after the vote and hopefully the company finally starts to deliver some groundbreaking news in May that validates the science to new investors. Only then will we see a spike in price.
The only real argument many long time shareholders have and it is a genuine one is that essentially NWBO are asking for an open checkbook without having to reveal any tangible evidence concerning the roadmap they plan for DCVAX-L over the coming year. A planned publication validating the belief in DCVAX-L has been promised for 6 months and yet we see or hear nothing.
Without any news leading into the vote expect the SP to be demolished into the teens.
Obviously NWBO is running out of time to get these shares issued and we cannot expect them to be held to ransom by the publishers, however investors can be given assurance by the company that all is well with the manuscript and let shareholders know that this manuscript along with other news such as Spring refresh is soon to follow the vote.
If the company is willing to part with some tangible information of upcoming events many longs on this board will gladly stick by the company.
Complete silence leading into the vote is considered by many as a bad omen because everyone is just being asked to trust in management even though they are diluting everyone's investment 3 fold and at the same time taking on substantial rewards for themselves.
I believe that we will see something before the vote because complete silence at this point is self defeating for everyone concerned.
$380,000 dollars of trades back and forth and almost 3 cents down shows you what is happening here. Facts are facts and no real longs with large stakes are selling right now. Price manipulation by certain players to try and force a fire sale which is not happening and will not happen regardless of upcoming vote. This continued downward pressure on very low volume will continue and all I can see is that this is a buying opportunity because who would sell at this pathetically low price. Only people selling are those trading in very small quantities or the naysayers trying to cause a panic.
Well said l4p, I believe that most true retail longs with large investments will ride this little storm with no loss of sleep. All eyes should be set on the future and remember the uptick of breadcrumbs offered up by the company these past 6 months. It all leads to eventual success no matter how you look at it. The publication may not be ready before the vote but no matter it will be delivered and be a definite positive when it does.
I believe the back chatter calling for "no" is just noise and those few investors sitting on the fence need to look back these past 6 months and readjust their goals once more. We are so close to something positive and voting "yes" should just confirm your belief in the science and put to bed your fears of no news before the vote.
We have all known about the dilution since December so what is the deal. Remember the right to try act is really close and that will be another huge boost for this little biotech.
Looking forward to something beautiful soon.
You have obviously spoken to Les because I do not think we will be seeing this article anytime soon. Why can the company not let all the investors know that the article has been either accepted or not by a publisher and give an estimate of when it will be published. The talk has now moved onto the fact that the SP will be better served if the article came after the vote. What this says is that the impact of the article is not that great because if the SP is affected negatively then what can we deduce. The article either validates the science in the eyes of the 67 scientists or it is a split opinion. Complete silence by the company on anything positive before the vote will drive the SP down into the teens because of the added extensive upcoming dilution.
We as investors have been setup to expect something that we thought would be critical to proving the science to new investors ever since the 8K on interim blinded data last year. Since then we have had massive dilution and nothing to convince anyone outside of the company of the validity of the article.
It looks like they are choosing not to unblind once again and allowing such massive dilution will allow the company to kick the can down the road while they work on Direct and combo's all the while resorting back to toxic financing in the teens.
Hope I am wrong but it is time that the company provide some information of their path forward concerning DCVAX-L which to all of us is the most critical of all trials right now.
Here are a couple of scenarios for the board to consider by the sudden 250M share increase taking total share count to 1.2B
1) Increasing the share count by an additional 250 million could indicate that the company is expecting to be trading in the penny range for some time and are not looking to unblind the data this year after maybe seeing the results of the Spring scrub. In this scenario they would still need millions of millions of shares to keep the lights on until next year and are expecting to continue toxic financing between 16 and 24 cents. This scenario would obviously be based on possibly a positive interim blinded paper indicating that the company is still hopeful of trial success but need to improve their overall OS figures by one more year. This paper would then be used to bring in new investors over the coming year into 2019.
2) If we are looking at a great publication and a big reveal and unblinding of DCVAX-L phase 3 at this years ASCO indicating success we would expect the SP to rise north of $2 and maybe as high as $5. 250 million shares multiplied by this SP would allow the company to raise up to a Billion dollars. What we should be asking ourselves is why would the company need this type of money other than they would be planning to go it alone and build themselves into a BP without any backing except future shareholders. In this scenario I would fully expect NWBO to merge with Cognate and Advent and possible rename themselves as Advent say for example.
We would all prefer option 2 at this point but I really question the amount of additional shares they are asking us to vote on and we as investors should be allowed to ask for real concrete information regarding a path forward so we can feel comfortable to dilute to the extent they are asking us to do.
Just my 2 cents.
This has nothing to do with the NWBO Publication we are all waiting for.
https://www.elsevier.com/books/handbook-of-brain-tumor-chemotherapy-molecular-therapeutics-and-immunotherapy/newton/978-0-12-812100-9
A lot of noise today regarding the additional 250M which granted caught many by surprise. Will we or won't we get to see the article before the call to vote is our biggest concern right now. Because LP has still not posted a guaranteed date for the vote leads me to believe that the publication is imminent. If a date is posted prior to vote after all that has been hyped these past few months may lead to a sell off from many concerned investors which I believe is not their aim. NWBO has a responsibility to its shareholders concerning this publication and the information contained within.
Question for the board. Are we within our rights as shareholders to request a copy of this publication before voting upon signing a non disclosure agreement.
It looks like they allowed non shareholders the right to view this document by making them sign a non disclosure.
Why can't we request the same.
Never a truer word spoken for those considering their investment. You either believe in the science and the company and will vote yes or you do not and therefore will sell your shares. If the company is upping the number of shares they must be supremely confident in the upcoming vote so this tells me we see publication soon shortly followed by an 8K announcing the date.
I think this individual will have a good idea what Eagle Rock was involved in and who they were connected to. Looks to be hedge fund related to me.
https://www.linkedin.com/in/jaredtoren/
Principal
Company Name Eagle Rock Capital, LLC
Dates Employed 2007 – May 2009 Employment Duration 2 yrs
Consulted and marketed hedge funds to institutional investors, family offices and high net worth individuals.
Here is a simple lesson to the Fudsters on this board about this so called huge downswing caused by people selling off in the reams.
How do these MM's manipulate these OTC stocks and cause large downswing and upswings depending on their agenda's. In the case of the last couple of days NITE or CDEL put out large ASKS always with a lower price pretending that they have this huge seller. As the market price draws close to their ASK they withdraw. Watch the games, so predictable it is boring and played across all these penny stocks.
Fudsters show this board the proof of every tick where there are really actual sellers with millions of shares (you talk about 100 million plus) who actually sell the quantities being displayed on the ASK and you will find none. This is all a smoke screen and as many are doing here time to buy as all these MM's are trying to do is scare people into selling their positions.
Ain't going to work with NWBO as the die has been cast and we now wait for the real games to begin.
No he is just completely clueless when it comes to SP manipulation by MM's and underhanded shorts running the price down by trading small quantities. Needs to stick to being a lawyer because this is not his game.
WOW, all $82,000 worth to bring it down so quickly, again shows some desperation here. No one selling that I can see. Keep up the BS, it ain't working.
And right on queue here come the Claytrader to try and rally the shorts. There is only one clear reason to sell right now and that is to drive the price down. Come on Fudsters, keep on selling for lower and lower prices as I am sure there are buyers out there no matter what. Lessismore, this game being played right now is so old it is boring. If you really think that the small volume traded today and I repeat miniscule volume when compared to 415,000,000 outstanding shares and a 10% drop is anything but scaremongering and a deliberated ploy to either catch those dumb enough to set stop losses or to ensue some type of panic selling then you are part of the dumb money crowd.
I will always choose positivism over negativism and CT80 is one really bent out of shape long if he is even one considering the amount of crumbs spread all over the place that point to a positive outcome rather than a negative one. Coming days, weeks and months will be truly interesting that's for sure.
Now April Fools Day would be the perfect date for the release of this publication. Would show a wicked sense of humor on the part of LP don't you think. A nice day to stick it to the fools who have tried to destroy something beautiful.
According to Fidelity/Google finance etc the outstanding shares are still at 329,712,000 and Mkt Cap of 110M. Not sure why Yahoo shows it as more but I tend to go with Fidelity over Yahoo Finance.
I had some orders out on the bid for a while and then relinquished and bought on the ask. To be truthful I am not going to play games for a meager .8 cents at this time even for a $40K order. If the science proves out there will be many out there wishing they had got in on these levels. Until there is news the herd grazes peacefully, but once it breaks look out for the stampede.
Here is a post on the Yahoo message board from Meifud a known fudster.
He references knowledge of the publication and the journal.
This is most likely lies but let's see what comes up in the next week or two.
meifud yesterday
publication will be in the Journal of Cancer Research and Clinical Oncology, and will share how the trial was designed, how patients were screened, how pseudoprogression diagnosis has been complicated by reaction to the vaccine, why the trial was redesigned and expanded, etc., and a lot of numbers from a year ago will appear again but with the caveat that comparison with the average survival of GBM patients has to factor in the screening criteria applied to phase III enrollees that was not applied to the general population of GBM patients
Well enjoy your beer and weekend, I will be cracking open a couple soon as well.
I seem to remember some of your projections but will review over the weekend.
So LIM, what is your best guess for Market Cap if DCVAX-L get's approval with D in the wings.
If you say less than KITE or JUNO's valuations then we all know that you are lying.
Now with that market cap what would be the PPS on current outstanding shares of 450M. We can do the math if share count increases to 900M
I do not like to count my pennies but I am also a realist when it comes to projecting market potential for these types of vaccines if they get approved. IF is the big question and depending on what side of the fence you are on will prove either a home run for longs or a close out for shorts.
Gone are the days of the wolf pack trying to bankrupt this company. Now who will the winner be and in that regard I am highly confident.
Agree here, I think most longs are locked and loaded and any new accumulation may be new buyers or longs that are still accumulating small quantities on a weekly basis depending on resources. Any selling is MM's keeping the price down. Leak of publication date will increase demand and SP. Great publication that points towards success will see most longs holding onto their positions and we could see a dramatic increase in SP as demand will sky rocket. Now as we know, anyone short legitimately or not would need to start covering and as long as we longs hold strong we will see large gains leading into the next binary event. For those events look at all the pointers stated in the 8K.
The only positive that came from such a reveal which to me disappointed many longs is the fact that they chose to reveal this information this year.
IMO this means that this spring is the end and turning point of this trial.
Publication of interim blinded results will be the start of a very exciting journey for all investors and believers of this science.
Yours and our disappointment will be short lived.
With you on this Sojo, my guess if volume starts to pick up is the 10th or 20th, most likely the 20th. The next few days will be telling but a Saturday publication would be beautiful weekend reading for all.